Does ANAMORELIN Cause Non-small cell lung cancer? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Non-small cell lung cancer have been filed in association with ANAMORELIN. This represents 6.2% of all adverse event reports for ANAMORELIN.
8
Reports of Non-small cell lung cancer with ANAMORELIN
6.2%
of all ANAMORELIN reports
6
Deaths
5
Hospitalizations
How Dangerous Is Non-small cell lung cancer From ANAMORELIN?
Of the 8 reports, 6 (75.0%) resulted in death, 5 (62.5%) required hospitalization, and 2 (25.0%) were considered life-threatening.
Is Non-small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAMORELIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ANAMORELIN Cause?
Malignant neoplasm progression (28)
Decreased appetite (14)
Interstitial lung disease (13)
Oedema peripheral (9)
Pyrexia (9)
Anaemia (7)
Hyperglycaemia (6)
Hypothyroidism (6)
Nausea (6)
Platelet count decreased (6)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
Which ANAMORELIN Alternatives Have Lower Non-small cell lung cancer Risk?
ANAMORELIN vs ANASTROZOLE
ANAMORELIN vs ANDEXANET ALFA
ANAMORELIN vs ANDROGEL
ANAMORELIN vs ANETHOLTRITHION
ANAMORELIN vs ANGIOTENSIN II